Lana Denysyk, Head of RWD Assets at Novo Nordisk, discusses the use of real-world data in biotech. She explores the diverse data ecosystem in organizations and the importance of understanding which data type best suits specific research questions. Lana also highlights the role of RWD professionals in facilitating broader access to data and the challenges of navigating privacy regulations. The chapter descriptions cover the integration of real-world data into biotech organizations, managing resource constraints, standardized processes, privacy regulations, and developing a data strategy for pharmaceutical companies.
